Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial
1996

Cisplatin/Carboplatin, Etoposide, and Vinorelbine in Advanced Lung Cancer

Sample size: 112 publication Evidence: moderate

Author Information

Author(s): P Comellal, G Frascil, G De Cataldis, N Panza, R Cioffi, C Curcio, M Belli, A Bianco, G Ianniello, L Maiorino, M Della Vittoria, J Perchard, G Comellal

Primary Institution: National Tumor Institute of Naples

Hypothesis

We hypothesised a 15% minimum increment in the response rate with the experimental regimen over the 25% expected activity rate of the standard regimen.

Conclusion

The experimental regimen does not improve the prognosis of advanced NSCLC patients in terms of response rate and overall survival.

Supporting Evidence

  • 15 responses were observed in arm A (28%) and 13 in arm B (25%).
  • Median survivals were similar in the two arms (31 vs 27 weeks).
  • Treatment did not affect the response rate significantly.
  • Stage IV and performance status 2 were significantly associated with a lower probability of response.
  • Four treatment-related deaths were registered in arm B compared to one in arm A.

Takeaway

Doctors tested a new combination of drugs for lung cancer but found it didn't work better than the standard treatment.

Methodology

A multicentre randomised phase III trial comparing two chemotherapy regimens in patients with advanced non-small-cell lung cancer.

Potential Biases

There was an imbalance in histological subtypes between treatment groups.

Limitations

The trial was stopped early due to a lower response rate in the experimental arm compared to the control.

Participant Demographics

Nearly 90% of patients were men, with more than 40% having poor performance status and over half having stage IV disease.

Statistical Information

P-Value

0.036

Confidence Interval

95% CI = 17-42 for arm A, 95% CI = 13-37 for arm B

Statistical Significance

p=0.036

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication